Yakira Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Yakira Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-265,195	Closed	-$5.71M	–	198
2025 Q4	$5.71M	Buy	+265,195	New	+$5.15M	1.92%	17

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yakira Capital Management's AVDL Position: Q1 2026 in Review

Yakira Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 265,195 shares — an estimated $5.71M sold.

Yakira Capital Management first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $5.71M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Yakira Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Yakira Capital Management sold 265,195 Avadel Pharmaceuticals shares in Q1 2026, an estimated $5.71M.
Yakira Capital Management first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Yakira Capital Management's Avadel Pharmaceuticals position peaked at $5.71M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Yakira Capital Management's 13F filing for Q1 2026, filed 14 May 2026.